Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2014
09/25/2014US20140288049 2-Thiopyrimidinones
09/25/2014US20140288048 Heterocyclic compounds and uses thereof
09/25/2014US20140288045 Covalent inhibitors of kras g12c
09/25/2014US20140288044 Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors
09/25/2014US20140288041 Aryl- or Heteroaryl-Substituted Benzene Compounds
09/25/2014US20140288033 Crystalline forms of a biphenyl compound
09/24/2014EP2781517A1 Nitrogenated heterocyclic compound
09/24/2014EP2781516A2 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid
09/24/2014EP2781510A1 HIV inhibiting 5,6-substituted pyrimidines
09/24/2014EP2780342A1 Aminoquinazoline derivatives and their salts and methods of use
09/24/2014EP2780341A1 Kinase modulating compounds, compositions containing the same and use thereof
09/24/2014EP2780338A1 Uracil derivatives as axl and c-met kinase inhibitors
09/24/2014EP2780337A1 Substituted cyclopropyl compounds useful as gpr119 agonists
09/24/2014EP2780332A1 Morpholinyl benzotriazine for use in cancer therapy
09/24/2014EP2780324A1 Heterocyclic carboxamides useful as inhibitors of phosphodiesterase type 10a
09/24/2014EP2780321A1 Mono-fluoro beta-secretase inhibitors
09/24/2014EP2780015A1 Muscarinic m1 receptor agonists
09/23/2014US8841459 3-arylamino pyridine derivatives
09/23/2014US8841458 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
09/23/2014US8841453 Hybrid cholinesterase inhibitors
09/23/2014US8841451 Methods of nanoassembly of a fractal polymer and materials formed thereby
09/23/2014US8841450 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841449 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841447 Process for the preparation of alogliptin
09/23/2014US8841337 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841336 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
09/23/2014US8841331 Inhibitors of human immunodeficiency virus replication
09/23/2014US8841327 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
09/23/2014US8841325 Immunomodulatory compounds for the restoration of vitamin D sensitivity in vitamin D resistant tumor cells
09/23/2014US8841324 Heterocyclic compounds as autotaxin inhibitors
09/23/2014US8841309 Substituted pyrazines and their use in the treatment of disease
09/23/2014US8841305 Activators of the human pyruvate kinase M2 receptor
09/23/2014US8841295 5-lipoxygenase-activating protein (FLAP) inhibitors
09/23/2014US8841290 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
09/23/2014US8841278 Antiviral compounds
09/23/2014US8840878 Peptidomimetic sulfamide compounds and antiviral uses thereof
09/23/2014CA2782347C Quinoline amide m1 receptor positive allosteric modulators
09/23/2014CA2651987C Piperidinyl derivatives as modulators of chemokine receptor activity
09/23/2014CA2612264C Heterocyclylaminoalkyl substituted benzimidazoles
09/23/2014CA2596393C 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
09/23/2014CA2584866C Mitotic kinesin inhibitors and methods of use thereof
09/23/2014CA2582347C Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
09/23/2014CA2575853C Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
09/23/2014CA2543199C Use of crth2 antagonist compounds in therapy
09/18/2014WO2014145485A2 Map kinase modulators and uses thereof
09/18/2014WO2014145040A1 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
09/18/2014WO2014145023A1 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
09/18/2014WO2014145004A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
09/18/2014WO2014144761A2 Increasing specificity for rna-guided genome editing
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014144087A1 Sovaprevir polymorphs and methods of manufacture thereof
09/18/2014WO2014143960A1 Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl) methanone compounds as cancer cell growth inhibitors
09/18/2014WO2014143915A1 Novel crystalline forms
09/18/2014WO2014143666A1 Hdac inhibitors
09/18/2014WO2014143612A1 6-[4-(1 h-imidazol-2-yl)piperidin-1 -yl]pyrimidin-4-amine derivatives as modulators of kinase activity
09/18/2014WO2014143609A1 Isoquinolines as potassium ion channel inhibitors
09/18/2014WO2014143608A1 Phthalazines as potassium ion channel inhibitors
09/18/2014WO2014142273A1 Dihydropyridazine-3,5-dione derivative
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014142086A1 Pyrrolidin-3-yl acetate derivative and piperidin-3-yl acetate derivative
09/18/2014WO2014142056A1 Salt of pyrrolidin-3-yl acetic acid derivative and crystals thereof
09/18/2014WO2014141187A1 Pyridine derivatives as rearranged during transfection (ret) kinase inhibitors
09/18/2014WO2014141175A1 Novel acrylamide derivatives as antimalarial agents
09/18/2014WO2014141091A1 Pyrrole derivatives as alpha 7 nachr modulators
09/18/2014WO2014140704A1 Indole compounds that activate ampk
09/18/2014WO2014140582A1 Kinase inhibitors
09/18/2014WO2014140310A1 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/18/2014WO2014140081A1 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014140076A1 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
09/18/2014WO2014140058A1 Compounds for improved stem cell differentiation into hepatocytes
09/18/2014WO2014139981A1 Dihydroquinoline-2-one derivatives for use as aldosterone synthase inhibitors
09/18/2014WO2014139391A1 Substituted pyridine compounds as kinases inhibitors
09/18/2014WO2014139325A1 Therapeutic compounds and compositions
09/18/2014WO2014139190A1 Nicotine compound, and preparation method and usage thereof
09/18/2014WO2014139145A1 Novel pyrimidine and pyridine compounds and usage thereof
09/18/2014WO2014139144A1 Therapeutic compounds and compositions
09/18/2014WO2013164337A9 Pyrimidine derivatives for the treatment of bacterial diseases
09/18/2014US20140275711 1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof
09/18/2014US20140275550 Lansoprazole compound and novel preparation method thereof
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140275534 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy) piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
09/18/2014US20140275531 Substituted pyridine and pyrazine compounds as pde4 inhibitors
09/18/2014US20140275529 Subunit selective nmda receptor potentiators for the treatment of neurological conditions
09/18/2014US20140275527 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
09/18/2014US20140275480 Novel processes for producing sovaprevir
09/18/2014US20140275182 Bicyclic pyrrole derivatives useful as agonists of gpr120
09/18/2014US20140275181 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140275176 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140275175 Organic compounds
09/18/2014US20140275168 Indirubin derivatives, and uses thereof
09/18/2014US20140275167 Hepatitis b antiviral agents
09/18/2014US20140275165 COMPOUNDS THAT INHIBIT NFkB AND BACE1 ACTIVITY
09/18/2014US20140275163 Sovaprevir polymorphs and methods of manufacture thereof
09/18/2014US20140275159 Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275158 Cyclohexyl isoquinolinone compounds
09/18/2014US20140275155 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275152 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140275135 Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
09/18/2014US20140275129 Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds
09/18/2014US20140275126 Processes and intermediates for preparing a medicament
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 1080